MAPT and Alzheimer disease: CSF NFL is higher in FTLD compared with AD. Replacing CSF total tau with CSF NFL in the neurochemical AT(N) framework increases the accuracy of the scheme at diagnosing FTLD as suspected non-Alzheimer pathophysiology (SNAP), with sensitivity increasing from 44 to 93% and specificity remaining high at 94%.